Nelson Textbook of Pediatrics 22nd Edition | Estrogen (17β-estradiol) for transgender females, testosterone for transgender males, puberty induction protocols, monitoring, adverse effects (VTE, polycythemia, dyslipidemia), fertility preservation, WPATH SOC 8, Endocrine Society guidelines.
🌐 paeds.online — Pakistan's Pediatric Platform| Medication | Route | Initial Dose (Puberty induction) | Adult Dose | Monitoring |
|---|---|---|---|---|
| 17β-estradiol | Oral/sublingual | 5 μg/kg/day | 2-6 mg/day | Estradiol, prolactin, VTE risk |
| 17β-estradiol | Transdermal | 6.25-12.5 μg/24h | 50-200 μg/24h | Estradiol, skin reaction |
| Testosterone cypionate/enanthate | IM/SubQ | 12.5 mg/m² weekly or 25 mg/m² q2wk | 30-100 mg weekly or 60-200 mg q2wk | Testosterone, CBC, lipids |